GPT and Thrombocytopenia: Most common adverse events were fatigue (49.5% vs. 33.8%), nausea (41.6% vs. 13.1%), thrombocytopenia (28.5% vs. 2.4%), ALT rise (28.5% vs. 5.6%), AST rise (23.1% vs. 5.7%), headache (28.4% vs. 16.9%), arthralgia (25.9% vs. 20.6%), epistaxis (21.5% vs. 3.5%), neuropathy (18.6% vs. 6.9%), constipation (17% vs. 8.2%), myalgia (15.4% vs. 11.1%), hot flashes (12.8% vs. 20.3%).